Literature DB >> 1315132

Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass.

Y J Gu1, W van Oeveren, P W Boonstra, J de Haan, C R Wildevuur.   

Abstract

The effects of cardiopulmonary bypass (CPB) on the expression of leukocyte adhesive receptors, ie, complement receptor type 3 (CR3), were studied in 16 patients. The CR3 expression on leukocytes was determined by time-resolved fluoroimmunoassay on a standardized number of cells isolated from blood samples taken during various times during CPB. The results demonstrated that CR3 expression on leukocytes increased immediately after the start of CPB (p less than 0.05), concomitant with an early sharp increase of plasma concentrations of C3a (p less than 0.01). After release of the aortic cross-clamp, a second peak of leukocyte CR3 expression was induced (p less than 0.05), paralleled by a significant increase of leukotriene B4 (p less than 0.05) and elastase (p less than 0.05) levels in the late period of CPB. In vitro studies with leukocytes isolated from healthy donors (n = 5) showed a dose-dependent increase of CR3 expression stimulated by zymosan-activated plasma, indicating that the rapid CR3 expression on leukocytes is likely mediated by complement activation. However, the mechanisms for the second peak of leukocyte CR3 expression during CPB remain to be further elucidated. In conclusion, CR3 expression on leukocytes increased immediately after the start of CPB and was followed by a second peak of expression in the late phase of CPB. Pharmacological blockage of these adhesive receptors might reduce the leukocyte-mediated deleterious effects of CPB.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315132     DOI: 10.1016/0003-4975(92)91447-h

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  The effects of extracorporeal whole body hyperthermia on the functional and phenotypic features of canine peripheral blood mononuclear cells (PBMC).

Authors:  R J Kearns; S Ringler; S Krakowka; R Tallman; J Sites; M J Oglesbee
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Longitudinal analysis of serum oxylipin profile as a novel descriptor of the inflammatory response to surgery.

Authors:  Arnaud M Wolfer; Alasdair J Scott; Claudia Rueb; Mathieu Gaudin; Ara Darzi; Jeremy K Nicholson; Elaine Holmes; James M Kinross
Journal:  J Transl Med       Date:  2017-04-26       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.